Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics
Hendrik Luesch, Ph.D., and Yousong Ding, Ph.D., co-authored the study that identified the genes responsible for producing dolastatin 10.
Hendrik Luesch, Ph.D., and Yousong Ding, Ph.D., co-authored the study that identified the genes responsible for producing dolastatin 10.
Researchers developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer.
The program aims to assist cancer researchers and clinician-scientists in becoming successful investigators.
The grants will support new and ongoing cancer screening and prevention projects across the state this year.
A look at how the UF Health Cancer Center is closing the care gap.
In an interview with Urology Times, Jonathan Chatzkel, M.D., discussed research on certain immunologically cold tumor types.
The UF Health Cancer Center's Research Showcase 2024 drew a record number of posters.
The award recognizes lifetime achievements in the practice of medicine.
In an OncLive interview, Ilyas Sahin, M.D., discussed the Northstar Response in patients with advanced gastrointestinal cancer undergoing treatment.
Researchers shed light on a pivotal mechanism regarding melanoma cells’ response to stress induced by chemotherapy agents.